Teenagers taking cancer drug to grow taller, doctors warn
Summarised from 2 outlets · Updated 10 Nov, 23:27 · Archive
Teenagers are taking the cancer medication erdafitinib illegally to try to grow taller, despite severe health risks.
Teenagers are taking erdafitinib, a prescription cancer medication approved to treat advanced bladder cancer, in an attempt to grow taller, according to reports of a social media trend known as 'heightmaxxing'. The drug is referred to online as 'ERDA' or 'Erta' and is being obtained on the black market.
Medical research has documented unexpected growth spurts in children receiving erdafitinib for brain tumors. A 2024 study published in Hormone Research in Paediatrics described accelerated growth in two paediatric patients, while another case report documented a teenager who grew more than 5 inches during treatment but developed serious skeletal complications.
Doctors warn that these growth spurts do not reflect healthy skeletal development. Dr. Jessica Gray, a family physician, warned that forced, rapid growth can trigger dangerous structural problems, including premature growth plate damage and bone fractures. Dr. Stephanie Widmer, an emergency medicine physician, said taking the drug without medical supervision can have 'devastating consequences'.
Johnson & Johnson stated that the medication has never been approved to stimulate height growth and that its safety and effectiveness have not been established for any paediatric or adolescent use.

How it is being reported
- Viral ‘heightmaxxing’ trend has teen boys taking cancer drugs to grow taller despite doctors’ warningsDoctors warn that teens taking erdafitinib, a cancer drug, to grow taller in a trend called heightmaxxing face severe health risks.New York Post · 10 Nov, 23:06
- Viral ‘heightmaxxing’ trend has teen boys taking cancer drugs to grow taller, doctors warn of risksErdafitinib, a cancer medication, is being misused by teens chasing height growth. Medical experts detail the severe risks of the heightmaxxing trend.Fox News · 10 Nov, 21:14
In this story: Erdafitinib · Johnson & Johnson · Dr. Stephanie Widmer · Dr. Jessica Gray
This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log
Comments (0)